Viemed Healthcare, Inc. (NASDAQ:VMD) Stake Cut by Paradigm Capital Management Inc. NY

Paradigm Capital Management Inc. NY lessened its holdings in Viemed Healthcare, Inc. (NASDAQ:VMD) by 62.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 150,000 shares of the company’s stock after selling 250,000 shares during the quarter. Paradigm Capital Management Inc. NY’s holdings in Viemed Healthcare were worth $1,203,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. R Squared Ltd bought a new position in shares of Viemed Healthcare during the fourth quarter worth about $41,000. Corton Capital Inc. bought a new position in Viemed Healthcare in the 4th quarter worth approximately $82,000. EntryPoint Capital LLC acquired a new stake in Viemed Healthcare in the 4th quarter valued at approximately $92,000. Prudential Financial Inc. bought a new stake in Viemed Healthcare during the 4th quarter valued at $93,000. Finally, Man Group plc bought a new stake in Viemed Healthcare during the 4th quarter valued at $95,000. Institutional investors own 74.24% of the company’s stock.

Viemed Healthcare Price Performance

Shares of NASDAQ VMD opened at $6.75 on Tuesday. The stock has a market cap of $266.79 million, a P/E ratio of 25.00 and a beta of 1.49. The firm’s 50-day simple moving average is $6.97 and its 200 day simple moving average is $7.81. Viemed Healthcare, Inc. has a fifty-two week low of $6.14 and a fifty-two week high of $9.81. The company has a quick ratio of 1.19, a current ratio of 1.31 and a debt-to-equity ratio of 0.03.

Viemed Healthcare (NASDAQ:VMD) last issued its quarterly earnings results on Wednesday, May 7th. The company reported $0.06 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.06. Viemed Healthcare had a return on equity of 8.72% and a net margin of 4.87%. The firm had revenue of $59.10 million during the quarter, compared to analyst estimates of $60.60 million.

About Viemed Healthcare

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.